Four-Year Survival With Durvalumab After Chemoradiotherapy in Stage III NSCLC-an Update From the PACIFIC Trial

Faivre-Finn, C; Vicente, D; Kurata, T; Planchard, D; Paz-Ares, L; Vansteenkiste, JF; Spigel, DR; Garassino, MC; Reck, M; Senan, S; Naidoo, J; Rimner, A; Wu, YL; Gray, JE; Ozguroglu, M; Lee, KH; Cho, BC; Kato, T; de Wit, M; Newton, M; Wang, L; Thiyagarajah, P; Antonia, SJ

Faivre-Finn, C (corresponding author), Christie NHS Fdn Trust, Wilmslow Rd, Manchester M20 4BX, Lancs, England.

JOURNAL OF THORACIC ONCOLOGY, 2021; 16 (5): 860

Abstract

Introduction: In the Phase 3, placebo-controlled PACIFIC trial of patients with unresectable, stage III NSCLC without disease progression after concur......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索